CARGO Therapeutics, Inc. Common Stock
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRGX research report →
Range $7 – $34
Price Chart
About the company
CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering innovative chimeric antigen receptor (CAR) T-cell therapies for patients battling cancer. Its primary therapeutic candidate is CRG-022, an autologous CD22 CAR T-cell product.
- CEO
- Anup Radhakrishnan
- IPO
- 2023
- Employees
- 167
- HQ
- San Mateo, DE, US
Get TickerSpark's AI analysis on CRGX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $216.19M
- P/E
- -1.59
- PEG
- 0.06
- P/S
- 0.00
- P/B
- 0.91
- EV/EBITDA
- -1.94
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -51.69%
- ROIC
- -59.31%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-7,074,000-91.6%
- Op Income
- $-187,370,000
- Net Income
- $-167,502,000-70.7%
- EPS
- $-3.72-56.3%
- OCF Growth
- -72.2%
- FCF Growth
- -59.9%
- 52W High
- $25.45
- 52W Low
- $3.00
- 50D MA
- $4.45
- 200D MA
- $7.81
- Beta
- 0.29
- RSI (14)
- 49
- Avg Volume
- 1.68M
No earnings-call transcripts are available for CRGX yet.
- Free Float
- 73.6%
- Shares Outstanding
- 48.36M
- Float Shares
- 35.61M
of shares held by institutions
115 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Nextech Invest Ltd. | 2.64M | 0 |
| Nuveen Asset Management, LLC | 75.93K | 0 |
| Nebula Research & Development LLC | 10.53K | ▼ 3.61K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 19, 25 | Dhingra Kapil | sell | 25,000 |
| Aug 19, 25 | Viswanadhan Krishnan | sell | 25,000 |
| Aug 19, 25 | Viswanadhan Krishnan | sell | 3,173 |
| Aug 19, 25 | Lubner David Charles | sell | 25,000 |
| Aug 19, 25 | Orwin John A | sell | 15,865 |
| Aug 19, 25 | Orwin John A | sell | 25,000 |
| Aug 19, 25 | Henderson Jane | sell | 25,000 |
| Aug 19, 25 | Bassan Abraham | sell | 25,000 |
| Aug 19, 25 | Huber Reid M | sell | 25,000 |
| Aug 18, 25 | Radhakrishnan Anup | other | 57,345 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CRGX coverage
Recent articles, reports, and earnings notes.
No research on CRGX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CRGX report →Shareholder Alert: The Ademi Firm Investigates Whether CARGO Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders
businesswire.com · Aug 8
CARGO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CARGO Therapeutics, Inc. - CRGX
businesswire.com · Jul 25
URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger - CRGX, HSON, BRZH, and ENZB
prnewswire.com · Jul 25
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of CARGO Therapeutics, Inc. (NASDAQ: CRGX)
globenewswire.com · Jul 9
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CRGX and WNS on Behalf of Shareholders
globenewswire.com · Jul 9
CARGO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CARGO Therapeutics, Inc. - CRGX
businesswire.com · Jul 9
Shareholder Alert: The Ademi Firm investigates whether CARGO Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders
prnewswire.com · Jul 8
CRGX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of CARGO Therapeutics, Inc. Is Fair to Shareholders
businesswire.com · Jul 8
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.